CIAM
CRMD icon

Caitong International Asset Management’s CorMedix CRMD Stock Holding History

Caitong International Asset Management’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.69K Sell
396
-2,526
-86% -$18.7K ﹤0.01% 1195
2025
Q4 		$34K Sell
2,922
-1,463
-33% -$16.2K 0.01% 848
2025
Q3 		$51K Buy
4,385
+3,813
+667% +$46.1K 0.04% 320
2025
Q2 		$7.05K Buy
572
+535
+1,446% +$5.91K 0.01% 869
2025
Q1 		$228 Buy
+37
New +$383 ﹤0.01% 1901

Other funds holding CRMD

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $3.39B AUM 105.5% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Caitong International Asset Management's CRMD Position: Q1 2026 in Review

Caitong International Asset Management reduced its CorMedix (CRMD) stake by 86% in Q1 2026, selling an estimated $18.7K and leaving 396 shares worth $2.69K. The position accounts for ﹤0.01% of the portfolio, ranked #1195.

Caitong International Asset Management first reported a position in CRMD in Q1 2025 and has held it in 5 quarters since. The position peaked at $51K in Q3 2025. 187 funds tracked by Wall St. Rank hold CRMD as of Q1 2026.

  • Caitong International Asset Management held 396 shares of CorMedix worth $2.69K as of Q1 2026.
  • Caitong International Asset Management sold 2,526 CorMedix shares in Q1 2026, an estimated $18.7K.
  • CorMedix made up ﹤0.01% of Caitong International Asset Management's portfolio in Q1 2026, its #1195 holding.
  • Caitong International Asset Management first reported a position in CorMedix in Q1 2025 and has held it in 5 quarters since.
  • Caitong International Asset Management's CorMedix position peaked at $51K in Q3 2025.
  • 187 funds tracked by Wall St. Rank held CorMedix as of Q1 2026.

Based on Caitong International Asset Management's 13F filing for Q1 2026, filed 11 May 2026.